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Introduction: A clinical pathway is a multidisciplinary plan of care based on best 
clinical practice for a specified group of patients with a particular diagnosis. It is designed to 
optimize resource utilization, and maximize quality of care. The efficacy and benefit of 
clinical pathway has been studied extensively in a few surgical fields and proven to be 
beneficial. However, the efficiency and benefit of clinical pathway implementation for 
laparoscopic appendicectomy in HUSM has yet to be studied. A clinical pathway for 
laparoscopic appendicectomy for acute appendicitis was developed in 2012 by the surgical 
team of HUSM in collaboration with the nursing staff, with a target length of stay of 3 days. 
Objectives: The aim of this study was to determine the cost of treatment of 
appendicitis patients under implementation of standard CP for laparoscopic appendicectomy 
in HUSM and to evaluate spectrum of variance in treatment of appendicitis under this clinical 
pathway.  
Methodology: All patients aged 12 or more, who were admitted to HUSM for 
suspected acute appendicitis and undergone treatment according to the clinical pathway from 
June 2014 until June 2016 was included in this study. Patients who had laparoscopic 
appendicectomy as part of other procedure, who were found intra-operatively to have 
diagnosis other than acute appendicitis, with significant co-morbid, and who require ICU care 
 
 
were excluded. The datasheet documents of the clinical pathway were collected, data on the 
treatment, cost of treatment, and variances in length of stay (LOS), cost and treatment were 
analysed.  
Result: 121 samples were collected and analysed. The mean cost of treatment was 
RM 1736.02. The mean LOS was noted to be 2.75 days, with standard deviation of 0.933 
days. Only 12.4% of patients had LOS of more than 3 days (negative variance), while 41.3% 
of patients actually had positive LOS less than 3 days. This means only 46.3% of patients had 
LOS of 3 days as per the pathway. Majority of the cause for negative LOS were due to delay 
of surgery for more than 1 day after patient was posted for surgery. Another major variance is 
in initiation of antibiotics, whereby only around 12% of patients receive antibiotics upon 
admission as per pathway.  
Conclusion: This study has identified the cost of treatment, and major variances in 
length of stay and certain treatment. Several modifications in the clinical pathway and 
changes in its implementation may be needed to improve its efficiency and benefit. 
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ABSTRAK 
Haluan klinikal adalah pelan jagaan pesakit yang melibatkan pelbagai kepakaran, 
berdasarkan praktis terbaik untuk sesuatu kumpulan pesakit dengan sesuatu penyakit tertentu. 
Ia adalah direka untuk memastikan pengurusan optima sumber, di samping mencapai kualiti 
jagaan pesakit terbaik. Efikasi and kebaikan haluan klinikal telah dikaji dengan menyeluruh 
dalam pelbagai bidang pembedahan, dan didapati memberikan pelbagai manfaat. 
Walaubagaimanapun, tahap keberkesanan dan manfaat haluan klinikal untuk pembedahan 
appendisektomi secara laparoskopik di HUSM belum lagi dikaji. Pada tahun 2012, Jabatan 
Pembedahan HUSM, bersama pasukan jururawat, satu haluan klinikal untuk appendisektomi 
secara laparoscopik  telah direka bentuk pada tahun 2012, dengan sasaran tempoh dalam wad 
selama 3 hari. Tujuan kajian ini adalah untuk mengenalpasti kos rawatan untuk pesakit akut 
appendicitis di bawah perlaksanaan haluan klinikal untuk pembedahan appendisektomi secara 
laparoskopik; dan juga untuk menilai spektrum variasi dalam rawatan apendisitis berdasarkan 
haluan klinikal ini. Semua pesakit berumur 12 dan ke atas, yang diwadkan di HUSM, disyaki 
mengidapi apendisitis akut, dan dirawat di bawah haluan klinikal ini daripada Jun 2014 
sehingga Jun 2016, telah dimasukkan dalam kajian ini. Manakala pesakit yang menjalani 
pembedahan laparoskopik apendisektomi sebagai sebahagian daripada pembedahan lain, 
ataupun didapati mengidap penyakit selain daripada apendisitis akut, mempunyai penyakit 
utama lain, ataupun memerlukan penjagaan rapi ICU adalah dikecualikan daripada kajian ini.  
Borang pengumpulan data haluan klinikal yang disi telah dikumpul, dan kos rawatan 
dikenalpasti; variasi tempoh dalam wad, kos rawatan, dan variasi dalam rawatan turut 
dianalisa. Sebanyak 121 subjek telah dikenalpasti, dikumpul dan dianalisa. Purata kos 
rawatan adalah sebanyak RM 1736.02 berdasarkan hasil kajian ini. Purata tepoh dalam wad 
didapati adalah 2.75 hari dengan deviasi standard 0.933 hari. Cuma 12.4% pesakit diwadkan 
lebih daripada sasaran 3 hari(variasi negative), manakala 41.3% pesakit diwadkan kurang 
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daripada 3 hari (variasi positif). Ini bermakna sebanyak 46.3% pesakit mengenai sasaran 
tempoh dalam wad selama 3 hari. Punca utama yang menyebabkan perlanjutan tempoh dalam 
wad adalah kerana kelewatan pembedahan dijalankan lebih daripada sehari selepas 
pembedahan dirancang. Manakala untuk rawatan antibiotic, cuma 12% pesakit menerima 
antibiotic pada masa pesakit diwadkan. Kajian ini telah dapat mengenal pasti kos rawatan, 
dan juga variasi utama dalam tempoh dalam wad serta variasi dalam rawatan tertentu. 
Beberapa ubahsuain dalam haluan klinikal dan juga cara perlaksanaannya mungkin 
diperlukan untuk menambahbaikkan efikasi dan manfaat daripada haluan klinikal ini. 
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ABSTRACT 
A clinical pathway is a multidisciplinary plan of care based on best clinical practice for a 
specified group of patients with a particular diagnosis. It is designed to optimize resource 
utilization, and maximize quality of care. The efficacy and benefit of clinical pathway has 
been studied extensively in a few surgical fields and proven to be beneficial. However, the 
efficiency and benefit of clinical pathway implementation for laparoscopic appendicectomy 
in HUSM has yet to be studied. A clinical pathway for laparoscopic appendicectomy for 
acute appendicitis was developed in 2012 by the surgical team of HUSM in collaboration 
with the nursing staff, with a target length of stay of 3 days. The aim of this study was to 
determine the cost of treatment of appendicitis patients under implementation of standard CP 
for laparoscopic appendicectomy in HUSM and to evaluate spectrum of variance in treatment 
of appendicitis under this clinical pathway. All patients aged 12 or more, who were admitted 
to HUSM for suspected acute appendicitis and undergone treatment according to the clinical 
pathway from June 2014 until June 2016 was included in this study. Patients who had 
laparoscopic appendicectomy as part of other procedure, who were found intra-operatively to 
have diagnosis other than acute appendicitis, with significant co-morbid, and who require 
ICU care were excluded. The datasheet documents of the clinical pathway were collected, 
data on the treatment, cost of treatment, and variances in length of stay (LOS), cost and 
treatment were analysed. 121 samples were collected and analysed. The mean cost of 
treatment was RM 1736.02. The mean LOS was noted to be 2.75 days, with standard 
deviation of 0.933 days. Only 12.4% of patients had LOS of more than 3 days (negative 
variance), while 41.3% of patients actually had positive LOS less than 3 days. This means 
only 46.3% of patients had LOS of 3 days as per the pathway. Majority of the cause for 
negative LOS were due to delay of surgery for more than 1 day after patient was posted for 
surgery. Another major variance is in initiation of antibiotics, whereby only around 12% of 
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patients receive antibiotics upon admission as per pathway. This study has identified the cost 
of treatment, and major variances in length of stay and certain treatment. Several 
modifications in the clinical pathway and changes in its implementation may be needed to 
improve its efficiency and benefit. 
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A. Study Protocol 
 
I. Document submitted for ethical approval 
Introduction and Literature Review 
The vermiform appendix is a blind end hollow organ with base opening into the posteromedial 
wall of the cecum 2cm below ileocecal valve. It is variable in length, commonly about 6 to 9 
centimetres. The submucosa of appendix contains many lymphoid mass and irregularly narrowed. 
The lumen is wider in children and may be obliterated in old age.  The location of the base of the 
appendix is usually constant however the position of the other part of it can be variable. The 
commonest location of the appendix is retrocecal, followed by pelvic position. The appendix is 
attached to the terminal ileum by the mesoappendix which contains appendicular artery, vein and 
lymphatics. The appendicular artery is usually a branch of the inferior division of ileocolic artery. 
The appendicular artery is an end artery, and may be thrombosed in appendicitis, leading to 
ischemic necrosis and rupture of the appendix. (Sinnatamby, 2011) 
Acute appendicitis is a common cause of abdominal pain and has a lifetime incidence of 8.6% in 
men, and 6.7% in women, typically occurring within the second and third decades of 
life.(ADDISS et al., 1990) In the United States alone, acute appendicitis affects 250,000 
individuals annually.(Kim et al., 2015) Factors predisposing to acute appendicitis include 
fecolith, food residues, foreign body, lymphoid hyperplasia in viral infection, and rarely 
carcinoid tumour, typhoid disease, actinomycosis and tuberculosis. (Raftery, 2008) 
The first appendicectomy occurred in 1735 by Claudius Amyand, Sergeant Surgeon to George II, 
performed the first known appendectomy. It was done during right scrotal hernia repair, during 
which he found a fistula from the appendix which was perforated by a pin. The appendix was 
2 
 
ligated and removed.(Shepherd, 1954) The term appendicitis was not coined until 1886 when 
Reginald Heber Fitz, pathologist of Harvard University presented a paper entitled “Perforating 
Inflammation of the Vermiform Appendix: With Special Reference to Its Early Diagnosis and 
Treatment.”(FITZ 1935)In 1889, McBurney published the first of several important papers 
regarding theappendix. He suggested early operative intervention and developed themuscle-
splitting incision that bears his name and is commonly used today.(McBurney, 1894) 
For over a century, open appendicectomy has been the gold standard of treatment for 
appendicitis.(Katkhouda et al., 2005) However in recent years, laparoscopy technique has been 
gaining attention and is used in treatment of appendicitis. Laparoscopic surgery is a form of 
minimal access surgical technique. It creates less surgical trauma compared to conventional open 
technique. It is achieved by insertion of rigid endoscope through a port in the abdominal wall to 
obtain access into the peritoneal cavity, which will be inflated with inert gas, usually carbon 
dioxide to create pneumoperitoneum. Further ports then can be placed, through which further 
surgical instruments can be inserted. (Darzi, 2004)A Cochrane review in 2010 involving 67 
studies comparing laparoscopic to open appendicectomy in adults concluded that use of 
laparoscopy and laparoscopic appendicectomy is patients with suspected appendicitis is 
recommended, especially in the young female, and obese. Hospital stay was shorter by 1.1 day 
and return to work and sports activity was earlier in patients who undergo laparoscopic 
appendicectomy. However, the duration of surgery is longer than open procedure by 10 minutes 
and cost of surgery is higher than open surgery. (Sauerland et al., 2010) 
Clinical pathway, also known as integrated care pathway, is a financial management tool that 
was initiated under Casemix System in the United States with the aim to reduce length of stay 
and reduce healthcare cost. (Takegami et al., 2003)  
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A Clinical Pathway (CP) is a multidisciplinary plan of care based on best clinical practice for a 
specified group of patients with a particular diagnosis. A CP is designed to minimize delays, 
optimize resource utilization, and maximizes quality of care (Reid et al., 2000) CPs support the 
implementation of Casemix by reducing variations of care, increasing homogeneity of cases, 
improving quality of Casemix data, and enhancing costing analysis in Casemix. (Aljunid et al., 
2011) 
(Rotter et al., 2010) further suggested the use of five criteria to for definition of clinical pathway, 
namely (1) the intervention was a structured multidisciplinary plan of care; (2) the intervention 
was used to channel the translation of guidelines or evidence into local structures; (3) the 
intervention detailed the steps in a course of treatment or care in a plan, pathway, algorithm, 
guideline, protocol or other inventory of actions; (4) the intervention had time frames or criteria-
based progression (that is, steps were taken if designated criteria were met); and (5) the 
intervention aimed to standardized care for a specific clinical problem, procedure or episode of 
healthcare in a specific population. 
They are used to translate clinical guidelines into local protocols and clinical practice and are 
now common place, particularly in the management of surgical conditions including appendicitis. 
(Campbell et al., 1998) Tan et al. had found significant reduction in readmission rate and 
postoperative morbidity rate in 204 patients undergoing major colorectal surgery managed using 
clinical pathway in 2001 in Singapore. There is also a reduction in length of stay by two days 
although not statistically significant (Tan et al., 2005) In a more recent study by Kulkarni, 
clinical pathway for endocrine surgery procedures, i.e. unilateral thyroid lobectomy, total 
thyroidectomy and parathyroidectomy, they achieved significant reduction in length of stay for 
all three procedures, and concurrent reduction of total cost for all procedures. However the post 
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operative morbidity was not assessed, although readmission rate within 72 hours post discharge 
had no significant difference. (Kulkarni et al., 2011) 
Clinical pathway is a vital component to be implemented in HUSM for a more cost effective 
management of cases in HUSM. Healthcare managers are always facing the challenge to provide 
acceptable service quality while keeping costs at a minimum, and in order to achieve this, 
knowledge of the actual cost of treatment of each patient is vital.(Javid et al., 2016) With reliable 
cost level estimates, only then can the hospital managers measure resource utilization and 
allocate accurately to eliminate inefficiency, promote transparency while maintaining 
productivity.(Porter, 2010; Vogl, 2013) unfortunately, cost analysis is not a simple task. Many 
factors affect cost estimation, namely patient characteristics, clinical activity, and of utmost 
significance, the costing method used. (Cartwright, 1999) 
 The efficacy and benefit of clinical pathway has been studied extensively in a few surgical fields 
(Müller et al., 2009) and proven to be beneficial. The reduction in length of hospitalization and 
also total cost of treatment had also been found in several studies, including (Uchiyama, 2002) 
who studied patients who undergo biliary and stomach laparoscopic surgery, (Quaglini, 2004) 
who studied on economic effects of clinical pathway in stroke patient management, and (Choong, 
2000) who conducted prospective study on patients with femur fracture. However, the efficiency 
of its implementation for acute appendicitis and laparoscopic appendicitis in our centre has yet to 
be studied. 
Casemix system has been implemented in HUSM since 2011. It was first initiated in United 
States of America by Professor Robert Fetter of Yale University in late 1970s, conceptually to 
simplify the complexity of patient specific diagnoses, by grouping similar diagnostic categories 
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into clinically meaningful diagnostic clusters, where resource use was also similar(Thompson et 
al., 1979)Case-Mix system is a classification of patient treatment episodes designed to create 
classes which are relatively homogenous in  respect of the resources used and which contain 
patients with similar clinical characteristics.(Reid et al., 2000) Casemix system “provides a 
means for examining the product of the hospital, since patients within each class are expected to 
receive a similar product”(Fetter et al., 1980)Casemix system has been first implemented in 
Malaysia in Universiti Kebangsaan Malaysia in 2002(Rohaizat, 2005), and has been launched 
officially in HUSM in 9 June 2013. Currently in HUSM, the main use of casemix system is for 
clinical quality measurement and improvement.   
 
Problem Statement 
Clinical pathway has never been initiated in HUSM Surgical Department. The feasibility and 
benefit of having such a pathway had not been studied in this institution. In fact in Malaysia only 
HUKM had published data on studies of clinical pathway (Aljunid, 2011). While many papers 
had been published on clinical pathway for a variety of disease, (Kulkarni, 2011) (Müller, 2009) 
its implementation and success in Malaysian hospital in general and specifically in HUSM had 
not been studied. More ever, it is in the principle of clinical pathway, that it is vital to tailor the 
pathway to suite a centre. Therefore in the process of developing a practical and beneficial 
clinical pathway, it is vital that the designed clinical pathway is evaluated systematically, and 
redesigned if necessary to ensure its practicality and efficacy. Findings from this study will give 
answer to the above problem.  
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Target Research Questions 
In initiating use of clinical pathway, a few questions will need to be addressed in the process of 
its development. Number one is if the clinical pathway is acceptable to the clinical staff. This 
question will be evaluated by documenting the variance rate of the patient management 
compared to the standard clinical pathway.  Another question is the cost of management of 
patients undergoing laparoscopic appendicectomy, and with this standard clinical pathway, how 
much is the average cost of treatment. 
 
General Objective: 
To evaluate the effectiveness of a standard clinical pathway for laparoscopic appendicectomy 
developed based on the consensus in HUSM. 
Specific Objectives: 
I. To determine the cost of treatment of appendicitis patients under implementation of standard 
CP for laparoscopic appendicectomy in HUSM. 
II. To evaluate spectrum of variance in treatment of appendicitis under implementation of 
standard CP for laparoscopic appendicectomy in HUSM 
 
Study Area 
Data collection for this study will be done in Hospital University Sains Malaysia (HUSM) 
Kubang Kerian, Kelantan. 
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Study Population 
Study population for this study will be all patients who are admitted to HUSM for suspected 
acute appendicitis, from June 2014 until June 2016. 
 
Inclusion Criteria: 
1. Patients aged more than 12 years old. 
2. Patients presenting to or referred to HUSM for suspected acute appendicitis 
3. Patients who undergo laparoscopic appendicectomy 
 
Exclusion Criteria: 
1. Patients who undergo appendicectomy as part of other procedure 
2. Patients who undergo open appendicectomy or interval appendicectomy  
3. Patients with complicated chronic condition or who require ICU care 
4. Patients who is found to have perforated appendix, appendicular abscess, normal 
appendix, or other pathology noted intraoperatively 
5. Patients with significant post operative complications such as bowel obstruction 
requiring parenteral nutrition. 
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Sample Size Estimation 
Sample size is estimated based the average of cases of acute appendicitis treated in HUSM from 
2014 to 2016.  The average cases per year are 248. Based on calculation using Raosoft, with 
margin of error of 5%, confidence level of 90%, sample size required for this study is 130. 
 
Sampling Method 
Simple random sampling method will be used; all patients admitted and treated according to the 
laparoscopic appendicectomy clinical pathway from June 2014 till June 2016 will be randomised 
for simple random sampling using SPSS. 
 
Data Collection 
Study Design and study population: 
This is a retrospective cross sectional study. 
A clinical pathway was developed in 2012 in HUSM. It was a designed mainly by the Surgical 
team of HUSM in collaboration with the nursing staff. The clinical pathway was implemented in 
2012. Each clinical pathway patient details and variation was recorded either by in charge staff 
nurse or doctors. The completed documents will be periodically collected by a Sister in charge as 
case manager.  
For this review, patients who had been admitted and treated according to this clinical pathway 
from April 2015 till April 2016 will be included. The datasheet documents will be collected from 
case manager and data key in using SPSS version 22 and analysed.  
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Data Analysis 
SPSS Statistical software, version 22 will be used for data analysis. Descriptive, prevalence and 
univariate analyses are among analyses will be conducted in order to accomplish the outlined 
specific objectives in this study. Costing analysis will be done by using Activity Based Costing 
method. All treatment activity, including staff salary, cost of blood and radiological investigation, 
medications, and cost of surgery will be taken into account. Variance in cost will be recorded and 
analysed. 
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Study Flow Chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Datasheet from April 2014 till 
April 2016 collected 
Costing analysis by Activity 
Based Costing Method 
Data key in SPSS 
Dissertation 
writing 
Data analysis 
using SPSS 
Ethical committee approval 
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T: 60!)- 'iti 7 .~o(KI -"'mb. ~:J~HI'l::W:! 
f : (j(.)}l - 767 2:J,J I 
E: jepem@usm.my 
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(JEPeM-USM). Your study has been assigned study protocol code USM/JEPeM/17010052, which 
should be used for all communication to the JEPeM-USM related to this study. This ethical clearance 
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approval through submission of JEPeM-USM FORM 3(8) 2015: Continuing Review 
Application Form. Subsequently this need to be done yearly as long as the research goes on. 
2. Any changes in the protocol, especially those that may adversely affect the safety of the 
participants during the conduct of the trial including changes in personnel, must be 
submitted or reported using JEPeM-USM FORM 3(A) 2015: Study Protocol Amendment 
Submission Form. 
3. Revisions in the informed consent form using the JEPeM-USM FORM 3(A) 2015: Study 
Protocol Amendment Submission Form. 
4. Reports of adverse events including from other study sites {national, international) using the 
JEPeM-USM FORM 3(G) 2014: Adverse Events Report. 
5. Notice of early termination of the study and reasons for such using JEPeM-USM FORM l(E) 
2015. 
6. Any event which may have ethical significance. 
<Approval><Dr. Chong Yi Chin><USM/)EPeM/ 17010052 Page 1 of2 
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7. Any information which is needed by the JEPeM-USM to do ongoing review. 
8. Notice of time of completion of the study using JEPeM-USM FORM 3(C) 2014: Final Report 
Form. 
Please note that forms may be downloaded from the JEPeM·USM website: -.jepem.kk.usm.my 
Jawatankuasa Etika Penyelidikan (Manusia), JEPeM-USM is in compliance with the Declaration of 
Helsinki, International Conference on Harmonization (ICH) Guidelines, Good Clinical Practice (GCP) 
Standards, Council for International Organizations of Medical Sciences (CIOMS) Guidelines, World 
Health Organization (WHO) Standards and Operational Guidance for Ethics Review of Health-Related 
Research and Surveying and Evaluating Ethical Review Practices, EC/IRB Standard Operating 
Procedures (SOPs), and Local Regulations and Standards in Ethical Review. 
Thank you. 
"ENSURING A SUSTAINABLE TOMORROW" 
Very truly yours, 
PR~ENBERGHE 
Chairperson 
Jawatankuasa Etika Penyelidikan (Manusia) JEPeM 
Universiti Sa ins Malaysia 
<Approvai><Dr. Chong Yi Chin><USM//EPeM/17010052 Page 2 of2 
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iJawatankuasa Etika P envelidikan Manusia USM (JEPeM) 
Ill "'' " ' 1: ' , ., I· 1-<f,, -·t """" " ' ''' ' l "" I I I ' H 
Date of meeting 
Venue 
Time 
Meeting No 
: 23'" March 2017 
: Meeting Room1 Division of Reseilrch & Innovation, 
USM Kampus Kesihaan. 
: 9.00 a.m- 3.00 p.m 
: 356 
Unlverslti Sains Malaysia 
KamjlliS t\,•silumln, 
Wl.iohulmn;,.:K~:rian, 
tid<tntau . .\lal >~y\i<l. 
I F: f iU!-J -7(j";' 'l:J.-.1 • E: j~:pc1n•(n1Mn.my I \\\\W.jr~~n.kk.u ... ~n.my 
Members of Committee of the Jawa~nltuasa Etika Penyelidlkan (Manusia), JEPeM Universiti Sa ins Malaysia wile reviewed 
the protocoVdocuments are os follows: 
Member Ocx:upetlon M ... / I Tlcll ("'I If present FemaW when allow (Tide and Name) (Des .... tlon) (M/F) ttems,werw 
reviewed 
Ch.!lrperson : .. 
·--·- --·· 
-
Professor Or. Hans Amtn van Chairperson of Jawatanlruasa Ellka M 
"' Rostenberghe Penyelidikan (Manusia), JEPeM USM (Chairperson) 
5ecremy: 
Mr. Mohd tuzlan Hafidz Mukrim Science Officer M 
"' 
Members: 
L ~Dr. Lee Yeonr Yeh Lecturer, School of Medical Sciences M 
"' 
l. 
- Professor Or. Mohtar Lecturer, School of Medical Sciences M 7 
lbra/>im 
3. Professor Dr. Nlk Hazlina Nik Lecturer, School of Medical SCiences F 
"' Hussain 
4. As>ocWII! Professor Or. Nor Lecturer, Sct.ool of Medical Sciences F 
"' Alwanv Yaacob 
s. Mn, Nor1eha Mohd Noor Executive Secretary, School of Dental F 
"' Sciences 
6. Associate Professor Oleksandr Lecturer, School of Health Sciences M 
"' Krasilshchikov 
,..,.,._~,~ •rurewr )f(l n•w• LectUrer; SChOol of Hea~nces F 
"' 
-·~····-
Ali 
8. Mn. Zilwlah Abu 8aka r Community Representative F 
"' 
9. Professor Dr. Zeehaida Lecturer, School of Medical Sciences F 7 
Mohamed 
--·-EliU Penyelldlk.., {Manu.,.), JEPeM-USM It if>"""'PIIence with tile--nld, 1-natl-· 
eont.renc:. on HllniiCinlzatlon (ICH) Guidelines, Good Clinical Practtc. (GCP) Studlnls. CDundl for lntanl8tional 
OrJanlullons of Medical Sd- (CIOM$) GuicleiiMS, Wor1d Health Orpnludon (WHO) Standanil •nd aper.tlonal 
Guidance for fillies hvlew of Health-Related Researdl and SUrveytn& and Evalu.UIII EtNatl hwlew PrKiicn, EC/IRB 
Staoldard Ope,..,. Prac:8dures (SOPs), and Local ReiUiatlons and Standards In Ethical-. 
~ 
PROFESSOR DR. HANS ANIIN VAN ROSTliNBERGHf 
Chairperson 
Jawatankuasa Etika Penyelldlkan (Manusia), JEPeM 
Unlversitl Sains Ma~ia 
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B. BODY CONTENT 
Introduction 
Introduction  
The vermiform appendix is a blind end hollow organ with base opening into the 
posteromedial wall of the cecum 2cm below ileocecal valve. It is variable in length, 
commonly about 6 to 9 centimeters. The submucosa of appendix contains many lymphoid 
mass and irregularly narrowed. The lumen is wider in children and may be obliterated in old 
age.  The location of the base of appendix is usually constant however the position of the 
other part of it can be variable. The commonest location of the appendix is retrocecal, 
followed by pelvic position. The appendix is attached to the terminal ileum by the 
mesoappendix which contains appendicular artery, vein and lymphatics. The appendicular 
artery is usually a branch of the inferior division of ileocolic artery. The appendicular artery 
is an end artery, and may be thrombosed in appendicitis, leading to ischemic necrosis and 
rupture of the appendix. (Sinnatamby, 2011) 
Acute appendicitis is a common cause of abdominal pain and has a lifetime incidence of 8.6% 
in men, and 6.7% in women, typically occurring within the second and third decades of 
life.(ADDISS et al., 1990) In the United States alone, acute appendicitis affects 250,000 
individuals annually.(Kim et al., 2015) Factors predisposing to acute appendicitis include 
fecolith, food residues, foreign body, and lymphoid hyperplasia in viral infection, and rarely 
carcinoid tumour, typhoid disease, actinomycosis and tuberculosis. (Raftery, 2008) 
The first appendicectomy occurred in 1735 by Claudius Amyand, Sergeant Surgeon to 
George II, performed the first known appendectomy. It was done during right scrotal hernia 
repair, during which he found a fistula from the appendix which was perforated by a pin. The 
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appendix was ligated and removed.(Shepherd, 1954) The term appendicitis was not coined 
until 1886 when Reginald Heber Fitz, pathologist of Harvard University presented a paper 
entitled “Perforating Inflammation of the Vermiform Appendix: With Special Reference to 
Its Early Diagnosis and Treatment.”(FITZ 1935)In 1889, McBurney published the first of 
several important papers regarding theappendix. He suggested early operative intervention 
and developed themuscle-splitting incision that bears his name and is commonly used 
today.(McBurney, 1894) 
For over a century, open appendicectomy has been the gold standard of treatment for 
appendicitis.(Katkhouda et al., 2005) However in recent years, laparoscopy technique has 
been gaining attention and is used in treatment of appendicitis. Laparoscopic surgery is a 
form of minimal access surgical technique. It creates less surgical trauma compared to 
conventional open technique. It is achieved by insertion of rigid endoscope through a port in 
the abdominal wall to obtain access into the peritoneal cavity, which will be inflated with 
inert gas, usually carbon dioxide to create pneumoperitoneum. Further ports then can be 
placed, through which further surgical instruments can be inserted. (Darzi, 2004)A Cochrane 
review in 2010 involving 67 studies comparing laparoscopic to open appendicectomy in 
adults concluded that use of laparoscopy and laparoscopic appendicectomy is patients with 
suspected appendicitis is recommended, especially in the young female, and obese. Hospital 
stay was shorter by 1.1 day and return to work and sports activity was earlier in patients who 
undergo laparoscopic appendicectomy. However, the duration of surgery is longer than open 
procedure by 10 minutes and cost of surgery is higher than open surgery. (Sauerland et al., 
2010) 
Clinical pathway, also known as integrated care pathway, is a financial management tool that 
was initiated under Casemix System in the United States with the aim to reduce length of stay 
and reduce healthcare cost. (Takegami et al., 2003)  
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A Clinical Pathway (CP) is a multidisciplinary plan of care based on best clinical practice for 
a specified group of patients with a particular diagnosis. A CP is designed to minimize delays, 
optimize resource utilization, and maximizes quality of care (Reid et al., 2000) CPs support 
the implementation of Casemix by reducing variations of care, increasing homogeneity of 
cases, improving quality of Casemix data, and enhancing costing analysis in Casemix. 
(Aljunid et al., 2011) 
(Rotter et al., 2010) further suggested the use of five criteria to for definition of clinical 
pathway, namely (1) the intervention was a structured multidisciplinary plan of care; (2) the 
intervention was used to channel the translation of guidelines or evidence into local structures; 
(3) the intervention detailed the steps in a course of treatment or care in a plan, pathway, 
algorithm, guideline, protocol or other inventory of actions; (4) the intervention had time 
frames or criteria-based progression (that is, steps were taken if designated criteria were met); 
and (5) the intervention aimed to standardized care for a specific clinical problem, procedure 
or episode of healthcare in a specific population. 
They are used to translate clinical guidelines into local protocols and clinical practice and are 
now common place, particularly in the management of surgical conditions including 
appendicitis. (Campbell et al., 1998) Tan et al. had found significant reduction in readmission 
rate and postoperative morbidity rate in 204 patients undergoing major colorectal surgery 
managed using clinical pathway in 2001 in Singapore. There is also a reduction in length of 
stay by two days although not statistically significant (Tan et al., 2005) In a more recent study 
by Kulkarni, clinical pathway for endocrine surgery procedures, i.e. unilateral thyroid 
lobectomy, total thyroidectomy and parathyroidectomy, they achieved significant reduction 
in length of stay for all three procedures, and concurrent reduction of total cost for all 
procedures. However the post operative morbidity was not assessed, although readmission 
rate within 72 hours post discharge had no significant difference. (Kulkarni et al., 2011) 
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Clinical pathway is a vital component to be implemented in HUSM for a more cost effective 
management of cases in HUSM. Healthcare managers are always facing the challenge to 
provide acceptable service quality while keeping costs at a minimum, and in order to achieve 
this, knowledge of the actual cost of treatment of each patient is vital.(Javid et al., 2016) With 
reliable cost level estimates, only then can the hospital managers measure resource utilization 
and allocate accurately to eliminate inefficiency, promote transparency while maintaining 
productivity.(Porter, 2010; Vogl, 2013) unfortunately, cost analysis is not a simple task. 
Many factors affect cost estimation, namely patient characteristics, clinical activity, and of 
utmost significance, the costing method used. (Cartwright, 1999) 
 The efficacy and benefit of clinical pathway has been studied extensively in a few surgical 
fields (Müller et al., 2009) and proven to be beneficial. The reduction in length of 
hospitalization and also total cost of treatment had also been found in several studies, 
including (Uchiyama et al., 2002) who studied patients who undergo biliary and stomach 
laparoscopic surgery, (Quaglini et al., 2004) who studied on economic effects of clinical 
pathway in stroke patient management, and (Choong et al., 2000) who conducted prospective 
study on patients with femur fracture. However, the efficiency of its implementation for acute 
appendicitis and laparoscopic appendicitis in our centre has yet to be studied. 
Casemix system has been implemented in HUSM since 2011. It was first initiated in United 
States of America by Professor Robert Fetter of Yale University in late 1970s, conceptually 
to simplify the complexity of patient specific diagnoses, by grouping similar diagnostic 
categories into clinically meaningful diagnostic clusters, where resource use was also 
similar(Thompson et al., 1979)Case-Mix system is a classification of patient treatment 
episodes designed to create classes which are relatively homogenous in  respect of the 
resources used and which contain patients with similar clinical characteristics.(Reid et al., 
2000) Casemix system “provides a means for examining the product of the hospital, since 
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patients within each class are expected to receive a similar product”(Fetter et al., 
1980)Casemix system has been first implemented in Malaysia in Universiti Kebangsaan 
Malaysia in 2002(Rohaizat, 2005), and has been launched officially in HUSM in 9 June 2013. 
Currently in HUSM, the main use of casemix system is for clinical quality measurement and 
improvement.   
 
Study Objective 
General Objective: 
To evaluate the effectiveness of a standard clinical pathway for laparoscopic appendicectomy 
developed based on the consensus in HUSM. 
Specific Objectives: 
III. To determine the cost of treatment of appendicitis patients under implementation of 
standard CP for laparoscopic appendicectomy in HUSM. 
IV. To evaluate spectrum of variance in treatment of appendicitis under implementation of 
standard CP for laparoscopic appendicectomy in HUSM 
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Rationale for Study 
Clinical pathway has never been initiated in HUSM Surgical Department prior to 2012. The 
feasibility and benefit of having such a pathway had not been studied in this institution. In 
fact in Malaysia only HUKM had published data on studies of clinical pathway (Aljunid, 
2011). While many papers had been published on clinical pathway for a variety of disease, 
(Kulkarni, 2011) (Müller, 2009) its implementation and success in Malaysian hospital in 
general and specifically in HUSM had not been studied. Moreover, it is in the principle of 
clinical pathway, that it is vital to tailor the pathway to suite a centre. Therefore in the process 
of developing a practical and beneficial clinical pathway, it is crucial that the designed 
clinical pathway is evaluated systematically, and redesigned if necessary to ensure its 
practicality and efficacy. Findings from this study will give answer to the above problem.  
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Methodology 
Study Area 
Data collection for this study was done in Hospital University Sains Malaysia (HUSM) 
Kubang Kerian, Kelantan. 
Study Population 
Study population for this study was all patients who were admitted to HUSM for suspected 
acute appendicitis and treated according to the clinical pathway, from June 2014 until June 
2016. 
Inclusion Criteria: 
4. Patients aged more than 12 years old. 
5. Patients presenting to or referred to HUSM for suspected acute appendicitis 
6. Patients who undergo laparoscopic appendicectomy 
Exclusion Criteria: 
6. Patients who undergo appendicectomy as part of other procedure 
7. Patients who undergo open appendicectomy or interval appendicectomy  
8. Patients with complicated chronic condition or who require ICU care 
9. Patients who is found to have perforated appendix, appendicular abscess, normal 
appendix, or other pathology noted intraoperatively 
10. Patients with significant post operative complications such as bowel obstruction 
requiring parenteral nutrition. 
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Sample Size  
Sample size was estimated based the average of cases of acute appendicitis treated in HUSM 
from 2014 to 2016.  The average cases per year were 248. Based on calculation using Raosoft, 
with margin of error of 5%, confidence level of 90%, sample size required for this study is 
130. After datasheet collection, only 145 completed clinical pathway datasheet were available, 
and after applying exclusion criteria, only 121 data were eligible for analysis. This will still 
give a confidence level of 87% with 5% margin of error. 
 
Study Design and Data Collection 
A clinical pathway for acute appendicitis treated by laparoscopic appendicectomy was 
developed in 2012 in HUSM. It was a designed mainly by the Surgical team of HUSM in 
collaboration with the nursing staff. It outlines all investigation and management of a patient 
with suspected acute appendicitis, from arrival to the Accident and Emergency Department, 
till surgery laparoscopiccally, until patient is discharged. All investigation, management and 
variance in management of the patient were recorded on the data collection sheet by the staff 
nurse incharge. The data collection sheet is as attached in the appendix. The completed 
documents will be periodically collected by a Sister in charge who acts as the case manager. 
In this study, all the available datasheet were collected from the case manager, and analysed. 
The full clinical pathway is attached in appendix. 
 
Costing Analysis 
Costing of the treatment was done using Activity Based Costing method. All treatment 
activity, including staff salary, cost of blood investigation and radiological investigation, 
medications, and cost of surgery was taken into account. For staff salary, pay of staff per 
